Medical Polymers Market is Expected to Reach $19,014 Million, Globally, by 2022 - Allied Market Research
PORTLAND, Oregon and PUNE, India, November 23, 2016 /PRNewswire/ --
Medical Polymers Market by Type (PVC, Polypropylene, Polyethylene, Polystyrene, Polycarbonate, PEEK, Hydrogel, Styrenic block copolymer, Rubber latex, Biodegradable, PLA, and Others), by Application (Surgical Instruments, Diagnostic Equipment, Orthopedic Implants, Electronic Implants, Dental Implants, Disposables, Packaging and Others) is expected to reach $19,014 million by 2022, growing at an estimated CAGR of 13.0% from 2016 to 2022, according to a new report published by Allied Market Research. Resins is the leading segment in 2015 and is expected to maintain its lead throughout the forecast period. Further, in the application segment, devices dominate occupying a share of nearly half of the global medical polymers market.
Summary of the medical polymers market report can be accessed on the website at https://www.alliedmarketresearch.com/medical-polymers-market
Medical polymers are widely used across various applications, as they are easy to manufacture and facilitate customizations. Moreover, they provide ease of fabrication, flexibility, and biocompatibility, and remarkable mechanical, electrical, chemical, and thermal properties of materials that are used as composites for medical implants. Increasing number of medical procedures, such as joint reconstruction & heart surgeries and rise in cosmetic and plastic surgeries in the developing countries are the few other key drivers of the market.
"Increase in adoption of medical polymers owing to low prices and versatility, coupled with increase in the sales of medical implants and devices globally will garner the growth of the global medical polymer market", said Eswara Prasad
Resins dominate the medical ceramics market due to a significant replacement trend of conventional medical devices materials with advanced polymers such as polyphenylene ether and few others, which provide high-quality medical devices. Further the application segment is led by devices holding nearly half of the global polymers market. This is mainly due to advancement in the technology provided by the polymers manufacturers such as polymer laminate technology and so on. Devices captured a major share in the global medical polymers market followed by disposables such as gloves, syringes and others.
Key Findings of the Medical Polymers Market
The bioresorbable plastics (PGA) of polymer market is expected to grow at a highest CAGR of 17.1% during the forecast period.
Resins hold the highest share of four-fifths of the total medical polymers market in 2015.
In the application segment, devices hold nearly half of the market share in 2015, where Diagnostics equipment contributes majorly towards the revenue of the segment.
Disposables is the fastest growing application segment and is expected to grow at an estimated CAGR of 14.2% during the forecast period of 2016-2022.
U.S. was the largest market in terms of demand for medical polymer in 2015.
The market for medical ceramics witnesses intense competition among the major players in the market. This competitive rivalry results into product innovation and development. Although the market is largely fragmented dominance of the major companies is characterized by their vast product portfolio for medical polymers, high investment in R&D, and strong distribution network. The companies have adopted various strategies such as agreement, product launch, product approval, merger & acquisition, collaboration, and investment to sustain the highly competitive environment of the medical polymers market.
Key companies profiled in this report include Eastman Chemical Company, Evonik Industries AG, The Dow Chemical Company, Formosa Plastics Corporation USA, Arkema SA, BASF SE, Covestro AG, DSM N.V., Solvay S.A, and Celanese Corporation.
Summary of similar reports can be viewed at
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions". AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
5933 NE Win Sivers Drive
#205, Portland, OR 97220
Toll Free: +1 (800) 792-5285 (U.S. & Canada)
Fax: +1 (855) 550-5975
Web: https://www.alliedmarketresearch.comEditor's Details
Last updated on: 24/11/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.